Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.37 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.37 |
| ▸ | PRMT8 | Q9NR22 | 2/20 | 0.37 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.37 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4377182 | 1.00 | CYP2C9 (0.46) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL5707199 | 0.91 | CYP2C19 (0.58) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL31034335 | 0.89 | CYP2C19 (0.56) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL12026375 | 0.88 | CYP2C9 (0.41) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL16328822 | 0.88 | CYP2C9 (0.37) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL16363716 | 0.88 | CYP2C9 (0.46) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL6131299 | 0.87 | CYP2C19 (0.58) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL31034296 | 0.86 | CYP2C19 (0.62) | CYP2C9CYP2C19TDP1CARM1PRMT6 | |
| SCHEMBL341302 | 0.86 | — | — | |
| SCHEMBL15189352 | 0.86 | PRMT1 (0.50) | CYP2C9CYP2C19TDP1CARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016033156-A1 | IRON-CATALYZED OXIDATIVE POLYMERIZATION OF PHENOLS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2016-03-03 | — | — | WO | disclosed |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| WO-2011107512-A1 | THE USE OF LINEAR TRIETHYLENTETRAMINE AS CURING AGENT FOR EPOXY RESINS | BASF SE (DE) | 2011-09-09 | — | — | WO | disclosed |
| WO-2010146009-A1 | METHYL-SUBSTITUTED TETA COMPOUNDS | BASF SE (DE) | 2010-12-23 | — | — | WO | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
| EP-1114836-B1 | PROCESS FOR PRODUCING A RESIN COMPOSITION | NAT INST OF ADVANCED IND SCIEN (JP) | 2006-11-08 | — | — | EP | disclosed |
| EP-1114836-A1 | RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME | Japan as represented by Secretary of Agency of Industrial Science and Technology (JP) | 2001-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | CYP2C9 166/4885CYP2C19 171/4885TDP1 1286/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | CYP2C9 159/4885CYP2C19 173/4885TDP1 1336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.